4.7 Article

Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease

期刊

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 108, 期 -, 页码 226-230

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2021.05.036

关键词

Kyasanur forest disease; Diagnosis; Point of care test; Real-time RT-PCR; Validation

向作者/读者索取更多资源

The study evaluated the diagnostic performance of Truenat KFD, a rapid point-of-care test for Kyasanur forest disease, comparing it with conventional RT-PCR testing. Truenat KFD showed high sensitivity and specificity, with detection limit comparable to gold-standard RT-PCR assays, making it useful for rapid diagnosis in remote and field settings.
Objectives: Due to the remote forest area locations of sporadic cases and outbreaks of Kyasanur forest disease (KFD), rapid diagnosis poses a significant challenge. This study aimed to evaluate the diagnostic performance of Truenat KFD, a simple, rapid and user-friendly point-of-care test for detection of KFD and compare diagnostic accuracy with conventional real-time reverse transcription-polymerase chain reaction (RT-PCR) testing. Truenat KFD can be deployed in a field laboratory setting. Methods: The study involved 145 clinical specimens, including human serum, monkey necropsy tissues and tick pool, to validate Truenat KFD (Molbio Diagnostics Pvt.Ltd.) for KFD diagnosis. Results: We have optimized and validated the microchip-based Truenat KFD (Molbio Diagnostics Pvt.Ltd.) for KFD diagnosis. Point-of-care testing was highly sensitive and specific, with a detection limit of up to 10 copies of KFD viral RNA. Results were comparable with the gold-standard TaqMan and commercially available Altona RealStar AHFV / KFDV real-time RT-PCR assays. Screening results for human, monkey and tick specimens were 100% concordant across the assays. Conclusion: Truenat KFD(Molbio Diagnostics Pvt.Ltd.) was found to be highly sensitive and specific with a significant limit of detection. This point-of-care test would be useful in rapid diagnosis of KFD in remote and/or field settings, quick patient management and control of virus spread. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据